Parkinsonís Will Double by 2040: Are We Ready?

This is an archived file of an event that took place on March 15, 2018.

Scientists predict the number of people with Parkinson's in the world will double by 2042 to more than 12 million. In this webinar, our expert panelists review some reasons behind the growth and strategies for addressing the "Parkinson's Pandemic."

Title: Parkinsonís Will Double by 2040: Are We Ready?

Duration: 1 hour

Continuing Medical Education Information for Health Care Professionals

MJFF offers Continuing Medical Education (CME) credit for practicing health care professionals for each Third Thursday Webinar. Click the link in the Resource List after viewing the webinar to take the post-test survey and receive your CME credit.

Date of Original Release:†March 15, 2018
Date Credit Expires:†March 15, 2020

Learning Objectives

  1. Discuss why the number of people with Parkinson's is projected to double by 2040.†
  2. List potential steps to limit the projected increase in Parkinson's.†
  3. Describe how we can increase access to care.†
  4. Summarize what people with Parkinson's can do today to live well, increase access to care and speed research.

Target Audience
This educational activity is designed for primary care physicians, family practice physicians, general medicine physicians, geriatricians, general neurologists, movement disorder specialists and any other health care practitioners who manage patients with Parkinson's disease.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Oakstone Publishing, LLC and The Michael J. Fox Foundation for Parkinson's Research. The Oakstone Publishing, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Oakstone Publishing, LLC designates this enduring material for a maximum of 1.0†AMA PRA Category 1 Creditsô. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Oakstone Publishing, LLC has assessed conflict of interest with its faculty, authors, editors and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing, LLC's planners, content reviewers, and editorial staff disclose no relevant commercial interests.


Bastiaan Bloem, MD, PhD
Medical Director
Professor of Neurology
Radboud University Nijmegen Medical Centre
Research Grants: Netherlands Organization for Scientific Research, Parkinson Vereniging, Princess Beatrix Foundation, Parkinson Vereniging, National Parkinson Foundation, Hersenstichting, UCB, Abbvie
Advisory Role: Zambon, Adamas, Kyowa Kirin
Employment: Radboudumc
Honoraria: Prof. Bloem has received fees for speaking at conferences from AbbVie, Zambon, Biall and Kyowa Kirin

Ray Dorsey, MD, MBA
David M. Levy Professor in Neurology
Director, Center for Health + Technology (CHeT)
University of Rochester Medical Center
Nothing to disclose

Dave Iverson
Nothing to disclose


Already Registered?

*Required Fields.

You must have Javascript and Cookies enabled to access this webcast. Click here for Help.

By registering you agree to receive email updates from
The Michael J. Fox Foundation. You can unsubscribe any time.